Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Division of Laboratory Systems, Center for Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Clin Infect Dis. 2022 Aug 31;75(3):416-424. doi: 10.1093/cid/ciab979.
Measles elimination (interruption of endemic measles virus transmission) in the United States was declared in 2000; however, the number of cases and outbreaks have increased in recent years. We characterized the epidemiology of measles outbreaks and measles transmission patterns after elimination to identify potential gaps in the US measles control program.
We analyzed national measles notification data from 1 January 2001 to 31 December 2019. We defined measles infection clusters as single cases (isolated cases not linked to additional cases), 2-case clusters, or outbreaks with ≥3 linked cases. We calculated the effective reproduction number (R) to assess changes in transmissibility and reviewed molecular epidemiology data.
During 2001-2019, a total of 3873 measles cases, including 747 international importations, were reported in the United States; 29% of importations were associated with outbreaks. Among 871 clusters, 69% were single cases and 72% had no spread. Larger and longer clusters were reported since 2013, including 7 outbreaks with >50 cases lasting >2 months, 5 of which occurred in known underimmunized, close-knit communities. No measles lineage circulated in a single transmission chain for >12 months. Higher estimates of R were noted in recent years, although R remained below the epidemic threshold of 1.
Current epidemiology continues to support the interruption of endemic measles virus transmission in the United States. However, larger and longer outbreaks in recent postelimination years and emerging trends of increased transmission in underimmunized communities emphasize the need for targeted approaches to close existing immunity gaps and maintain measles elimination.
美国于 2000 年宣布消除麻疹(中断地方性麻疹病毒传播);然而,近年来病例和疫情有所增加。我们对麻疹疫情和消除麻疹后麻疹传播模式的流行病学特征进行了描述,以确定美国麻疹控制计划中的潜在差距。
我们分析了 2001 年 1 月 1 日至 2019 年 12 月 31 日期间的全国麻疹报告数据。我们将麻疹感染集群定义为单个病例(未与其他病例关联的孤立病例)、2 例集群或暴发疫情,暴发疫情至少有 3 例关联病例。我们计算了有效繁殖数(R),以评估传染性的变化,并审查了分子流行病学数据。
2001-2019 年,美国共报告了 3873 例麻疹病例,包括 747 例国际输入病例;29%的输入病例与疫情有关。在 871 个集群中,69%为单个病例,72%无传播。自 2013 年以来,报告了更大和更长的集群,包括 7 起超过 50 例、持续时间超过 2 个月的暴发疫情,其中 5 起发生在已知免疫不足、关系密切的社区。没有一种麻疹谱系在单一传播链中循环超过 12 个月。近年来,R 的估计值更高,尽管 R 仍低于 1 的流行阈值。
当前的流行病学情况继续支持美国中断地方性麻疹病毒的传播。然而,近年来消除麻疹后的更大和更长疫情以及免疫不足社区传播增加的新趋势强调了需要采取有针对性的方法来缩小现有的免疫差距,并保持消除麻疹。